GLP-1s and Surgery: The Fasting Guidance That Changed, and Why It Matters

Published: 2026-08-01 · Last reviewed: 2026-08-04 · Methodology v4.1 · Journal
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · journal · corrections.

GLP-1 receptor agonists slow gastric emptying. That is part of how they work, and it means a standard pre-operative fast may leave stomach contents behind — raising the risk of aspiration under anaesthesia. Anaesthesia bodies have issued guidance on this. Tell any surgeon, anaesthetist or endoscopist that you take a GLP-1, including a compounded one.

Why this is a real problem and not a theoretical one

Pre-operative fasting rules assume a normal rate of gastric emptying. A drug that deliberately slows that rate breaks the assumption the rules are built on. Case reports of residual gastric contents after adequate fasting are what prompted formal guidance.

What changes, and what it means for you
AssumptionNormalOn a GLP-1
Stomach empty after a standard fastGenerally yesNot reliably
Aspiration risk under anaesthesiaBaselinePotentially raised
Standard fasting interval sufficientYesMay not be
Applies to compounded productsYes — the drug matters, not the label

This is a summary of the concern, not clinical guidance. Your anaesthetist decides.

The specific failure mode with compounded products. A patient on brand Wegovy generally tells the surgical team they take Wegovy. A patient on a compounded preparation from a telehealth platform frequently describes it as "a weight-loss shot" or does not mention it at all, because it does not feel like a prescription drug in the way a branded pen does. It is the same molecule with the same effect on gastric emptying. Say the drug name and the dose.

What the guidance covers

Which procedures this covers

Procedures where the question applies
General anaesthesia1Deep sedation1Endoscopy or colonoscopy1Dental sedation1Local anaesthetic only0

1 = raise it. Anything involving sedation or general anaesthesia, including procedures people do not think of as surgery.

What this page does not settle

The one action this page is confident about: tell them. It costs nothing and it is the step that lets everything else happen.

What to say, in one sentence

At pre-op assessment, and again on the day: "I take [drug name] at [dose], [weekly or daily], and my last dose was [date]." That single sentence contains everything the team needs to decide, and it works whether the product is branded or compounded.

What to have ready
DetailWhy they need it
Drug nameSemaglutide, tirzepatide and liraglutide differ in duration
DoseEffect on gastric emptying is dose-related
Date of last doseDetermines the interval before the procedure
Weekly or dailyDifferent clearance profiles
Branded or compoundedThey will ask; the drug is what matters

Five details, one sentence. Have them written down rather than recalled.

Common questions

Will my surgery be cancelled?

Not necessarily. Guidance exists so teams can manage the risk — adjusting fasting, assessing on the day, or modifying anaesthetic technique. The situation that causes cancellation is finding out late, not the drug itself.

What if it is an emergency?

Different considerations apply, and the team manages it. Tell them anyway — it changes how they assess.

Does this apply to a colonoscopy?

Yes. Anything involving sedation, including endoscopy, colonoscopy and dental sedation. Delayed gastric emptying also affects bowel-prep adequacy, which is a second reason to raise it.

How long before should I stop?

That is a clinical decision that depends on drug, dose, timing and procedure. It is not a self-directed one, and stopping abruptly without advice has its own consequences.

Why guidance emerged when it did

Pre-operative fasting rules are decades old and were written for a population not taking a drug that deliberately slows gastric emptying. As GLP-1 use grew, case reports began describing residual gastric contents in patients who had fasted appropriately — the specific scenario the rules exist to prevent.

Anaesthesia bodies responded with guidance rather than prohibition, because the risk is manageable when known and unmanageable when not disclosed. That distinction is the entire practical content of this page.

Where the risk actually sits
ScenarioRisk
Team knows, plans accordinglyManaged
Team knows on the dayManageable, may delay
Team does not knowThe scenario the guidance exists to prevent
Patient stopped the drug without adviceOwn consequences, and the team still needs to know

The variable that changes the outcome is disclosure, not the drug.

The related question: bowel prep

Delayed gastric emptying also affects bowel preparation adequacy before a colonoscopy. An inadequate prep means a repeat procedure, which is a different harm from aspiration but a real cost. Raise the GLP-1 when the prep is prescribed, not when you arrive.

Common questions

Should I stop before a dental procedure?

If it involves sedation, tell them and let them decide. If it is local anaesthetic only, the gastric emptying question does not arise in the same way — but telling them costs nothing.

What if I only take a compounded product?

The molecule is what matters. Say the drug name and dose, not "a weight-loss shot" — that phrase does not tell an anaesthetist what they need.

Is this a reason not to take a GLP-1?

No. It is a reason to disclose it, which is true of most medicines before a procedure.

What the team needs from you, by usefulness
Drug name3Dose3Date of last dose3Weekly or daily2Branded or compounded1

3 = changes the assessment directly. All five fit in one sentence.

What this page does not settle

One action this page is confident about: tell them, early, with the drug name and the date of your last dose. Everything else follows from that and nothing follows without it.

Why people do not mention it

Three reasons come up repeatedly, and none of them is carelessness. Some people do not think of a weekly injection as a medication in the way a daily tablet feels like one. Some are prescribed through a telehealth platform and have no local record, so it never appears on a list anyone else can see. And some are simply not asked — a pre-operative questionnaire written before this drug class was common may not prompt for it at all.

The consequence is the same in each case: a team that would have planned around it does not know. If the form does not ask, say it anyway. It is the one line on this page that has no downside and a large upside, and it takes five seconds.

Not medical advice. This page reports what published trials and manufacturers state. It is not a diagnosis, a dosing instruction or a recommendation for any individual. Every efficacy figure here was collected on an FDA-approved product; no compounded preparation has a trial of its own. Talk to a licensed clinician before starting, changing or stopping any medication.